524202 Stock Overview
Lactose (India) Limited manufactures and trades in pharmaceutical products in India.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 4/6 |
| Financial Health | 4/6 |
| Dividends | 0/6 |
Lactose (India) Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₹165.30 |
| 52 Week High | ₹173.65 |
| 52 Week Low | ₹40.20 |
| Beta | 0.38 |
| 1 Month Change | 17.23% |
| 3 Month Change | 11.43% |
| 1 Year Change | 275.60% |
| 3 Year Change | 522.60% |
| 5 Year Change | 408.62% |
| Change since IPO | 28,900.00% |
Recent News & Updates
Recent updates
Shareholder Returns
| 524202 | IN Pharmaceuticals | IN Market | |
|---|---|---|---|
| 7D | 9.0% | -2.5% | -2.5% |
| 1Y | 275.6% | 55.2% | 44.5% |
Return vs Industry: 524202 exceeded the Indian Pharmaceuticals industry which returned 55.2% over the past year.
Return vs Market: 524202 exceeded the Indian Market which returned 44.5% over the past year.
Price Volatility
| 524202 volatility | |
|---|---|
| 524202 Average Weekly Movement | 5.7% |
| Pharmaceuticals Industry Average Movement | 6.0% |
| Market Average Movement | 6.9% |
| 10% most volatile stocks in IN Market | 10.1% |
| 10% least volatile stocks in IN Market | 4.3% |
Stable Share Price: 524202's share price has been volatile over the past 3 months.
Volatility Over Time: 524202's weekly volatility (6%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1991 | 109 | Atul Maheshwari | www.lactoseindialimited.com |
Lactose (India) Limited manufactures and trades in pharmaceutical products in India. The company is involved in the drugs, medicines, chemicals, foods, etc. It offers lactose monohydrate; dry granulated, film, and lacquer coated tablets; and pharmaceutical products in solid dose forms. In addition, the company provides disaccharide lactulose, an active pharmaceutical ingredient that is used in the treatment of constipation, hepatitis encephalopathy, intestinal microflora, dental care, diabetes, and chronic liver disease, as well as for use as a prebiotic.
Lactose (India) Limited Fundamentals Summary
| 524202 fundamental statistics | |
|---|---|
| Market cap | ₹2.02b |
| Earnings (TTM) | ₹52.81m |
| Revenue (TTM) | ₹1.10b |
39.4x
P/E Ratio1.9x
P/S RatioIs 524202 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 524202 income statement (TTM) | |
|---|---|
| Revenue | ₹1.10b |
| Cost of Revenue | ₹554.66m |
| Gross Profit | ₹550.15m |
| Other Expenses | ₹497.34m |
| Earnings | ₹52.81m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
May 30, 2024
| Earnings per share (EPS) | 4.19 |
| Gross Margin | 49.80% |
| Net Profit Margin | 4.78% |
| Debt/Equity Ratio | 92.2% |
How did 524202 perform over the long term?
See historical performance and comparison